A r t i c l e s NIR fluorophores have great promise for in vivo imaging because of their reduced tissue absorbance, scatter and autofluorescence at NIR wavelengths between 700 nm and 900 nm (reviewed in refs. [1] [2] [3] . Two commercially available NIR fluorophores, IRDye800-CW (CW800) and Cy5.5, have highly hydrophobic cores surrounded by a shell of highly anionic surface charge. This chemical and geometric configuration results in relatively high nonspecific binding in vitro and in vivo [4] [5] [6] . When used in vivo, targeted imaging reagents are often cleared through the liver, leading to contamination of the gastrointestinal tract 7 and making it difficult to achieve a sufficient SBR, defined as the amount of signal in a region of interest relative to the amount of signal in a neighboring region.
Attempts to improve the SBR through background reduction have focused mainly on creating NIR fluorophores whose signals are modified by the local environment. Two of many examples (reviewed in ref. 8 ) are enzyme-activated fluorescent probes [9] [10] [11] [12] and pH-sensitive agents that have increased quantum yields after endocytosis and transport to lysosomes 13, 14 . In both of these examples, a quencher is released, leading to increased signal in response to certain proteases (for enzyme-activated fluorescent probes) or low pH (for pH-sensitive agents). However, none of the approaches to date focuses on a fundamental limitation of NIR fluorophores, namely, their nonspecific binding, uptake and retention.
A complementary approach that is applicable to nearly any targeting molecule is to create NIR fluorophores that have low nonspecific binding and, when used in vivo, are cleared by renal filtration, thereby preventing contamination of the gastrointestinal tract. The hypothesis guiding our work is that targeted zwitterionic molecules (molecules containing evenly spaced and interspersed positive and negative charges) might recapitulate the results obtained previously with targeted zwitterionic nanoparticles [15] [16] [17] [18] . In that previous work, zwitterionic surface coatings, but not anionic or cationic coatings, resulted in much lower than expected nonspecific uptake.
In a previous study characterizing the properties of NIR fluorophores, we found that the zwitterionic heptamethine indocyanine NIR fluorophore ZW800-1 has low serum binding, ultralow nonspecific tissue background and rapid elimination from the body through renal filtration 19 . Moreover, ZW800-1 has notable optical properties, including a high extinction coefficient and high quantum yield, ensuring maintenance of a high signal.
Here we conjugated the zwitterionic NIR fluorophore ZW800-1 to various targeting ligands and compared these with conjugates made using CW800 and Cy5.5 in a broad spectrum of biomedical optical imaging assays. We chose CW800 and Cy5.5 for this comparison because they have the best reported performance and highest number of citations in the literature. Our results suggest that targeted zwitterionic NIR fluorophores outperform conventional NIR fluorophores in a wide variety of in vitro and in vivo assays.
RESULTS

Physiochemical properties of targeted NIR fluorophores
To create targeted ZW800-1 (emission ~800 nm), CW800 (heptamethine indocyanine with a cyclohexene center that emits at ~800 nm) and Cy5.5 (linear pentamethine that emits at ~700 nm), we covalently conjugated each fluorophore to a cyclic peptide consisting of cyclo(RGDyK) (cRGD), which specifically binds integrin α v β 3 (Fig. 1a) . The signal-to-background ratio (SBR) is the key determinant of sensitivity, detectability and linearity in optical imaging. As signal strength is often constrained by fundamental limits, background reduction becomes an important approach for improving the SBR. We recently reported that a zwitterionic near-infrared (NIR) fluorophore, ZW800-1, exhibits low background. Here we show that this fluorophore provides a much-improved SBR when targeted to cancer cells or proteins by conjugation with a cyclic RGD peptide, fibrinogen or antibodies. ZW800-1 outperforms the commercially available NIR fluorophores IRDye800-CW and Cy5.5 in vitro for immunocytometry, histopathology and immunoblotting and in vivo for image-guided surgery. In tumor model systems, a tumor-to-background ratio of 17.2 is achieved at 4 h after injection of ZW800-1 conjugated to cRGD compared to ratios of 5.1 with IRDye800-CW and 2.7 with Cy5.5. Our results suggest that introducing zwitterionic properties into targeted fluorophores may be a general strategy for improving the SBR in diagnostic and therapeutic applications.
A r t i c l e s
We synthesized ZW800-1 using a process compatible with good manufacturing practices (Supplementary Fig. 1 ) 20 . Because of their starting anionic charges, cRGD-CW800 and cRGD-Cy5.5 had net surface charges of −4 and highly unbalanced (i.e., dipole-like) charge-to-hydrophobicity distributions over their surfaces. In contrast, cRGD-ZW800-1 was very hydrophilic (logD = −9.77), had a net surface charge of 0 and had an extremely well balanced charge distribution over its surface (Fig. 1a) . Molecular modeling (Fig. 1a) suggested that the indole nitrogen of those conjugates may be buried after conjugation and thus would not make a notable contribution to surface charge.
Cell binding assays, histology and immunoblotting
We next confirmed the specificity of targeted NIR fluorescent ligands to the surface of living cancer cells using human melanoma cell lines. All of the targeted fluorophores bound to α v β 3 -positive M21 cells but not to α v β 3 -negative M21-L cells (Fig. 1b) . However, we found high background signals from nonspecific binding of cRGD-CW800 and cRGD-Cy5.5 in both cell lines, whereas we detected almost no measurable background signal using cRGD-ZW800-1. To determine whether background reduction is also present when using large protein-targeting ligands, we conjugated NIR fluorophores to a secondary antibody (Supplementary Methods) and tested the NIR fluorescent antibody conjugates on breast cancer cells. HER2-overexpressing MDA-MB-361 breast cancer cells showed specific membrane binding with all three antibody-NIR conjugates (Fig. 1c) ; however, we found notably higher background signals in the HER2-negative MDA-MB-231 cells when using secondary antibodies conjugated to CW800 or Cy5.5. In addition, cells stained with only the secondary antibody conjugated to Cy5.5 showed strong nonspecific binding in both breast cancer cell lines.
In histopathology, the gold standard for diagnosing many human diseases, it is difficult to obtain an adequate SBR because many antigens are present in low abundance or are not highly concentrated. To compare the performance of the three NIR fluorophores for immunostaining, we conjugated each one to an antibody and used it to stain tissue sections (Fig. 2, Supplementary Fig. 2 and Supplementary Table 1 ). We fixed, froze and consecutively cryosectioned resected human tumor-containing tissues from prostatectomies ( Fig. 2a) and mastectomies ( Fig. 2b) for alternating NIR fluorescence and hematoxylin and eosin (H&E) staining. Using primary antibodies specific for the tumor of interest, an unlabeled secondary antibody for amplification and NIR fluorophore-labeled tertiary antibodies, we were able to readily identify malignant cells. However, antibodies conjugated to CW800 or Cy5.5 showed notable nonspecific background binding even when used at a fluorophore-to-antibody ratio of 1.2. Increasing the labeling ratio to 2.5 ( Supplementary Fig. 3 ) increased the background even further despite the presence of 0.1% nonionic detergent and 0.1% albumin in all solutions.
Immunoblotting is often used to confirm the presence of a target protein in a complex biological sample. By using NIR fluorescent light, background signals from autofluorescence and light scattering of membranes can be greatly reduced. However, challenges and limitations remain with respect to sensitivity and quantification. The zwitterionic antibody conjugate improved the SBR by lowering nonspecific membrane staining, eliminating false-positive bands or both ( Supplementary Fig. 4 ). 
A r t i c l e s
Tumor targeting and image-guided surgery Achieving an adequate tumor-to-background ratio (TBR; defined as the contrast-to-background ratio (CBR) from the tumor divided by the CBR from nearby normal tissue), CBR (defined as the signal−system background divided by the system background) and positive-to-negative tumor ratio (PNR; defined as the CBR from a receptor-positive tumor divided by the CBR from a receptor-negative tumor in the same animal) is challenging for most targeted contrast agents. Using a xenograft mouse model containing transplanted human melanoma cells (either the α v β 3 -positive M21 cell line or the α v β 3 -negative M21-L cell line), we compared the performance of the three NIR-conjugated cRGD ligands. After intravenous administration of 2-10 nmol of each NIR-conjugated cRGD into tumor-bearing mice, the TBR and SBR of the α v β 3 -positive xenografts increased over a 4 h observation period. The highest TBR (17.2 ± 1.2 (mean ± s.d.)), SBR (5.1 ± 0.7) and PNR (4.2 ± 0.9) at 4 h after injection were achieved using cRGD-ZW800-1 (Fig. 3a) . With both cRGD-CW800 and cRGD-Cy5.5, the signal in the α v β 3 -positive tumors was similar to that with cRGD-ZW800-1, as might be expected because their affinities, extinction coefficients and quantum yields are similar. However, the backgrounds in nontumor tissues and α v β 3 -negative tumors were much higher with cRGD-CW800 and cRGD-Cy5.5 than with cRGD-ZW800-1 (TBR, 5.1 ± 1.2 and 2.7 ± 1.4; SBR, 2.6 ± 0.2 and 1.4 ± 0.2; PNR, 2.1 ± 1.0 and 1.4 ± 1.1 for cRGD-CW800 and cRGD-Cy5.5, respectively), which is indicative of lower specificity and selectivity. After 4 h, washout from the tumors occurred. Although the background decreased, the TBRs for cRGD-ZW800-1, cRGD-CW800 and cRGD-Cy5.5 were 4.8, 2.0 and 1.3, respectively, by 24 h (Supplementary Fig. 5a ). Image-guided surgical resection of major tissues and organs at 4 h revealed extremely low uptake with cRGD-ZW800-1 in normal tissues and organs (Supplementary Fig. 5b ).
The signal in skin with cRGD-ZW800-1 was probably caused by the normal expression of integrins in skin 21 . In addition, cRGD-ZW800-1 was eliminated from the body exclusively through renal filtration and was unchanged in urine when analyzed by mass spectrometry, whereas less than 30% of the other targeted agents were present in urine at 4 h after injection (data not shown). We next tested these NIR-conjugated cRGD ligands in liver and lung metastatic tumor models because small metastases are difficult to detect where the nonspecific background is high. Fluorescence signal intensities at the target tumor were similar using each of the three targeted NIR ligands (Fig. 3b) . However, cRGD-ZW800-1 expressed almost no background fluorescence in liver and lung tissues, whereas cRGD-CW800 showed high background in the thoracic wall, abdominal wall and liver, and cRGD-Cy5.5 resulted in elevated background in most tissues, including lung, liver, gallbladder, abdominal wall and thoracic wall. The highly saturated signal from stomach was caused by autofluorescence at 700 nm.
The identification of occult bleeding (i.e., fibrinogen-positive thrombi) in real time could permit surgeons to intervene intraoperatively to repair damaged tissue. We therefore tested the ability of NIR-labeled fibrinogen (FBG; FBG-ZW800-1, FBG-CW800 and FBG-Cy5.5; Supplementary  Fig. 6 ) to visualize blot clots in rat models of bleeding in the stomach (Fig. 3c) and mesenteric vessels ( Fig. 3c and Supplementary Fig. 6b) 22 . Because the labeling ratios of fluorophores to fibrinogen are similar with each agent (~2.5), we found similar fluorescence intensities in all of the injected rats. However, the intensities of the background signals were notably different. FBG-ZW800-1 accumulated rapidly at the site of thrombus formation and achieved an optimal CBR within 60 min after injection, probably owing to rapid blood clearance of FBG and low nonspecific uptake. In contrast, almost no background reduction was achieved over the same time course by FBG-CW800. Because of autofluorescence at 700 nm, the CBR of FBG-Cy5.5 remained low throughout the entire time course. Overall, the lower background of FBG-ZW800-1 compared to FBG-CW800 and FBG-Cy5.5 contributed to a twofold to fivefold higher CBR at 1 h after injection in both mucosal and mesenteric sites. Control fluorophores without fibrinogen showed no accumulation at any injury site (data not shown). of prostate tissue using a rabbit human α-methylacyl-CoA racemase (AMACR)-specific primary antibody (Ab; top), goat rabbit-specific secondary (2′Ab) and NIR-conjugated mouse goat-specific tertiary antibodies (3′Ab) alone (middle) and the NIR fluorophores alone (2 µM each; bottom). All NIR fluorescence images had identical exposure times and are normalized to the peak signal. (b) H&E (left) and NIR fluorescence immunostaining (right) of breast tissue using a rabbit human HER2-specific primary antibody (top), goat rabbit-specific secondary and NIR-conjugated mouse goatspecific tertiary antibodies alone (middle) and the NIR fluorophores alone (2 µM each; bottom). All NIR fluorescence images had identical exposure times and are normalized to the peak signal. Scale bars, 200 µm.
npg DISCUSSION Surgery is the mainstay of cancer treatment, contributing to a cure for approximately half of all patients diagnosed annually. Although many cancer-targeted contrast agents have been described in the literature and some are available commercially, none perform optimally in vivo owing to a high nonspecific background. Similarly, in vitro diagnostics, such as cell-based assays, histopathology and immunoblotting, are often hampered by a high background and, therefore, a relatively low SBR. The only two ways to improve the SBR during optical imaging are to raise the signal or lower the background. However, for antigen-targeted NIR fluorophores, there is a fundamental limit to signal strength because of the relatively low number of binding sites and intrinsic properties of the fluorophore, such as the extinction coefficient, quantum yield and excitation fluence rate. Although amplification can be used to raise low signals for in vitro diagnostics, amplification during in vivo imaging is often complex and clinically unrealistic. Our study focused on improving the SBR by lowering the background. Even though the NIR window of 700-900 nm provides relatively high photon transmission and relatively low autofluorescence, nonspecific binding, uptake or both of conventional NIR fluorophores is the major problem impeding the field. We describe reagents for quantitatively imaging metastatic tumors during surgery, cells on a microscope slide or bands on an immunoblot with much less background signal than when using conventional NIR fluorophores.
Two key findings warrant highlighting. First, the physicochemical structure of a relatively small NIR fluorophore can substantially degrade the performance of both small and large targeting molecules. As shown in Figure 4 , when a primary amine is conjugated to a tetrasulfonated molecule, the single positive charge present at physiological pH is replaced by three net-negative charges, which can disrupt local protein folding, alter the isoelectric point of the molecule and increase nonspecific binding to cationic surfaces. In a zwitterionic fluorophore, however, the amino acid residue has the same net charge with which it started. Because of the implications of this observation, we tested two different chemical classes of NIR fluorophores in parallel, as well as targeting ligands spanning the entire spectrum from small molecules to large proteins. This phenomenon has also been seen in cell-based assays, histopathological immunostaining, immunoblotting, in vivo tumor imaging and image-guided surgery, suggesting that it is indeed a general phenomenon. Although the precise mechanism by which zwitterionic structure lowers the background is not known, previous studies suggest a combination of charge shielding 23, 24 and minimization of membrane penetration 25, 26 .
Second, the strategy of using small, polyionic yet net-neutral molecules with geometrically balanced charge for in vivo imaging leads Fig. 6 ). CBRs (bottom graphs) were calculated from the ratio of the signal at the site of injury site to the nearby normal tissue background. Arrows indicate injury sites. Statistical analysis was performed using one-way analysis of variance followed by Tukey's multiple-comparison test (*P < 0.05, **P < 0.01 or ***P < 0.001 for ZW vs. CW, ZW vs. Cy5.5, CW vs. Cy5.5). All NIR fluorescence images had identical exposure times and are normalized to the peak signal. Error bars, mean ± s.d. Scale bars, 1 cm.
A r t i c l e s to clearance exclusively through the kidney and complete elimination of any unbound dose from the body into the urine ( Supplementary  Fig. 5 ). This observation could be important in not only optical imaging but also diagnostic imaging and drug design. Zwitterionic radiometal chelators or zwitterionic fluorinated (or other radiolabeled) ligands could reduce the background and improve the SBR in positron-emission tomography and single-photon emission computed tomography imaging. It should be noted that both of these imaging technologies are capable of detecting tumors over tenfold smaller than those currently imaged clinically, but they cannot achieve this potential because of the high background of conventional radiotracers 27 . Similarly, therapeutic molecules, such as membrane-targeted radiotherapeutics and cytotoxins, could achieve a wider therapeutic window if nonspecific binding to normal cells were avoided through the introduction of zwitterionic chemical structure.
One potential problem with this general strategy for small molecules is that the blood half-life might sometimes be too short for adequate target contact when using low-affinity ligands. This can be corrected with an inert bulking domain such as polyethylene glycol. Species-specific blood elimination rates are also important. In previous studies 19, 20 , the blood half-life and renal clearance of zwitterionic NIR fluorophores were proportional to the glomerular filtration rate. Because pigs and humans have similar glomerular filtration rates 28 , it is probable that the urine elimination rates in pig are similar to those in human models.
The name ZW800-1 includes '-1' because a final net charge of 0 is achieved after conjugation to a ligand with a −1 residual charge 19 . However, we believe that the delocalized, positively charged indolium may be buried within the hydrophobic core of the molecule (Fig. 1a) and may not contribute to the surface charge in some configurations. In such a case, the balanced net surface charge may be the dominant predictor of low background adsorption and uptake. A fundamental question arising from our data is whether a geometrical balance of charge over the entire surface of a targeted molecule is necessary. That is, would a molecule with polyionicity and net neutrality but separation of charge in a more dipole-like geometry have the properties of low nonspecific binding and uptake in vitro and in vivo? Ongoing studies aim to answer this question and develop a mathematical model for predicting targeted ligand performance on the basis of physicochemical parameters.
In addition to improving the sensitivity and specificity of fluorescence-based in vitro diagnostics, our study should improve image-guided surgery, especially image-guided cancer surgery. In a well-designed optical system, NIR fluorescence has the potential to detect collections of tumor cells on the surface of a tissue (i.e., margin positivity) as small as 100 cells or fewer. This level of tumor-cell detection is currently only available using postoperative histopathological analysis, which typically takes 3-5 working days to reveal whether margins are positive. An ultralow background with a concomitantly higher SBR is the only way to achieve this theoretical level of cancer-cell detection.
First-in-human clinical trials of ZW800-1 are in process. From the small-and large-animal data already analyzed, it seems that the dose of targeted zwitterionic NIR fluorophores in humans will fall into an acceptably low range. When the dose is scaled by body surface area, which we have found to be the best scaling factor for targeted NIR fluorophores 29, 30 , 100 pmol per g body weight of ZW800-1 in a 20 g mouse (2 nmol) is equivalent to a human dose of ~0.43 mg. This is 58-fold lower than the typical vial size of indocyanine green (25 mg), the only 800-nm fluorophore that has been approved by the US Food and Drug Administration for use in vivo. This calculation suggests that ZW800-1-targeted small molecules will have reasonable human dosing. Because ZW800-1 was engineered to have a single carboxylic acid that facilitates stable amide bond formation to amine-containing targeting ligands, one-step 'modular chemistry' for producing cancerspecific, small-molecule diagnostic agents 31 , as well as one-step conjugation to antibodies and other targeting biomolecules, is possible.
METHODS
Methods and any associated references are available in the online version of the paper. 
